DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-30 Cr | ₹18 Cr | ₹-165 Cr | ₹159 Cr | ₹210 Cr |
What is the latest Consolidated Net Profit of DISHMAN CARBOGEN AMCIS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-30 Cr |
Mar2023 | ₹18 Cr |
Mar2022 | ₹-165 Cr |
Mar2021 | ₹159 Cr |
Mar2020 | ₹210 Cr |
How is Consolidated Net Profit of DISHMAN CARBOGEN AMCIS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-30 Cr | Negative | |
Mar2023 | ₹18 Cr | Positive | |
Mar2022 | ₹-165 Cr | Negative | |
Mar2021 | ₹159 Cr | -24.64 | |
Mar2020 | ₹210 Cr | - |
Compare Consolidated Net Profit of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹3,935.7 Cr | -2.5% | -10.2% | 52.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | -2.5% |
-10.2% |
52.1% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses